RexGene Biotech to patent a formula for anti-cholesterol.

Published: 2005-12-28 06:56:00

Updated: 2005-12-28 06:56:00

RexGene Biotech announced that the formula containing an extract of Sophorae fructus was registered to the Patent Office for the prevention and treatment of hyperlipidemia, arteriosclerosis and fat liver diseases.

The company said that the extract of Sophorae fructus showed a lowering effect ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK